Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Secretin-Enhanced CT for Pancreatic Cancer Screening
NCT00587132Phase 2Terminated
- Sponsor
- Mayo Clinic
- Start
- Nov 2006
- Primary completion
- Feb 2012
- Modality
- Peptides, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of secretin in pancreatic cancer (PC), sponsored by Mayo Clinic. Started Nov 2006; status: terminated.
02
Drugs
secretin
03
Conditions
pancreatic cancer (PC)
Beyond the preview
Go deeper on NCT00587132.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00587132.